Skip to main content
. Author manuscript; available in PMC: 2018 Sep 1.
Published in final edited form as: Am Heart J. 2017 Jul 1;191:75–81. doi: 10.1016/j.ahj.2017.06.016

Table 2.

Baseline Characteristics of Regional/Ethnic Groups (N=5,697)

Characteristic White Black or African American Indian Malay Chinese Japanese & Koreans p-value
N=1,324 N=674 N=1,448 N=590 N=973 N=688
Age, median (IQR),)y 61.7 (54.3–70.1) 54.9 (46.8–63.9) 59 (51–66) 56 (49–63) 62 (52–70) 67 (54.5–75) <0.001
Men (%) 79.1 60.7 76 80.5 81.0 73.7 <0.001
NYHA classification (%) (N=5692) <0.001
 * Class I/II 63.4 60.1 54.7 58.2 45.3 61.3
 * Class III/IV 36.6 39.9 31.9 37.4 46.9 27.5
 * Not assessed 0 0 13.5 4.4 7.8 11.2
Left ventricular ejection fraction, mean (SD), (%) 24 (6.1) 24 (6.4) 27 (5.6) 24 (6.3) 26 (6.3) 26 (6.5) <0.001
Ischemic etiology (%) (N=5469) 61.6 33.1 42.9 69.4 45.5 31.8 <0.001
Systolic blood pressure, mmHg, mean (SD) (N=5663) 113 (18) 116 (19) 116 (18) 122 (22) 120 (20) 114 (19) <0.001
Heart rate, bpm, mean (SD) (N=5664) 71 (11) 72 (12) 81 (15) 83 (18) 80 (17) 77 (16) <0.001
BMI (kg/m2) (N=5494) 30.1 (6.2) 33.1 (8.4) 25.0 (4.9) 25.8 (5.8) 24.6 (4.9) 23.2 (4.1) <0.001
Serum creatinine, mg/dL, mean (SD) (N=4668) 1.36 (0.9) 1.34 (0.7) 1.26 (0.8) 1.59 (1.6) 1.38 (1.1) 1.41 (1.4) <0.001
Comorbidities, n (%)
* Diabetes (N=5684) 388 (29.3) 242 (35.9) 584 (40.3) 278 (47.7) 369 (38.0) 221 (32.4) <0.001
* Atrial fibrillation/flutter (N=5685) 327 (24.7) 96 (14.2) 64 (4.4) 78 (13.4) 238 (24.5) 249 (35.9) <0.001
* Hypertension (N=5672) 668 (50.8) 510 (76.0) 586 (40.5) 342 (58.7) 529 (54.4) 328 (48.0) <0.001
* Stroke (N=5685) 100 (7.6) 109 (16.2) 30 (2.1) 39 (6.7) 68 (7.0) 69 (10.1) <0.001
* COPD (N=5669) 161 (12.3) 54 (8.1) 73 (5.0) 51 (8.8) 102 (10.5) 62 (9.1) <0.001
* Chronic kidney disease (N=4656) 604 (51.7) 214 (34.6) 354 (37.3) 258 (57.2) 358 (43.1) 267 (41.8) <0.001
* Smoking history (N=5677) 891 (67.5) 381 (56.9) 313 (21.6) 346 (59.3) 530 (54.5) 364 (53.4) <0.001
* Alcohol intake, Yes (N=5652) 595 (45.5) 243 (37.0) 251 (17.3) 73 (12.4) 332 (34.1) 309 (45.3) <0.001
Educational status, n (%) <0.001
* Less than high school 158 (11.9) 93 (13.8) 408 (28.2) 147 (24.9) 358 (37.0) 118 (18.1)
* High school or equivalent 326 (24.6) 234 (34.7) 444 (30.7) 284 (48.1) 372 (38.5) 218 (33.4)
* Some college/associate degree/diploma 446 (33.7) 229 (34.0) 177 (12.2) 68 (11.5) 150 (15.5) 100 (15.3)
* Degree or higher 359 (27.1) 106 (15.7) 371 (25.6) 70 (11.9) 63 (6.5) 186 (23.5)
* Decline to respond/nil 35 (2.6) 12 (1.8) 48 (3.3) 21 (3.6) 24 (2.5) 30 (4.6)
Medications, n (%)() (N=5543)
* Beta-blockers 1244 (94.0) 645 (95.7) 937 (68.3) 415 (74.6) 789 (83.8) 579 (85.8) <0.001
* ACE inhibitors/Angiotensin receptor blockers 1236 (93.4) 639 (94.8) 1050 (76.5) 428 (77.0) 640 (67.9) 564 (85.6) <0.001
* Mineralocorticoid receptor antagonists 575 (43.4) 340 (50.5) 833 (60.7) 310 (55.8) 627 (66.6) 390 (57.8) <0.001
* Diuretics 998 (75.4) 565 (83.8) 1106 (80.6) 483 (86.9) 769 (81.6) 541 (80.2) <0.001
All-Cause Mortality, n (%) 57 (4.3) 42 (6.2) 107 (8.3) 70 (17.4) 116 (13.7) 27 (4.8) <0.001